Neonatal Hyperbilirubinemia, Types, Causes and Treatments: A Review Study
DOI:
https://doi.org/10.46966/msjar.v2i2.23Keywords:
Hyperbilirubinemia, Bilirubin, Neonate JunduiceAbstract
Neonatal hyperbilirubinemia results from a readiness for the bilirubin production in neonates and limited their ability to excrete it. The diagnosis of hyperbilirubinemia based on yellow discoloration of the skin and whiteness of eyes, idle in the child's movement and the lack of lactation. The baby seems sick or is difficult to awaken. Bilirubin is a tetrapyrrole pigment derived from breakdown product of normal heme catabolism in senescent red blood cells. Unconjugated bilirubin normal elevation is named newborn physiologic hyperbilirubinemia, whereas the level of bilirubin of infant normally to be a bit higher after birth, In the same context the placenta in the womb of the mother. Pathologic hyperbilirubinemia is defined as odd of bilirubin from the normal level so intervention required. Many reasons for this type of jaundice
References
American Academy of Pediatrics (AAP), (1994). Practice Parameter: Management of Hyperbilirubinemia in the Healthy Term Newborn. Pediatrics, 94:558-566.
Bertini, G.; Dani, C.; Trochin, M. and Rubaltelli, F., (2001). Is breastfeeding really favoring early neonatal jaundice? Pediatrics, 107(3): 41.
Bryon, J.; Lauer, M.D.; Nancy, D. and Spector, M.D., (2011). Hyper- bilirubinemia in the Newborn. Pediatrics in Review, Vol.32(8).
Buescher, JJ. ; Bland, H.,(2011) . Care of the newborn. In: Rakel RE, ed. Textbook of Family Medicine. 8th ed. Philadelphia, PA: Saunders Elsevier; chap 22.
Cabra, M.A.; Whitfield, J.M., (2005). The challenge of pre venting neonatal bilirubin encephalopathy: a new nursing protocol in the well newborn nursery. Proceedings (Bayl Univ Med Cent), 18: 217–9.
Click, R.; Dahl-Smith J.; Fowler, L.; DuBose, J.; Deneau-Saxton, M. and Herbert, J., (2013). An osteopathic approach to reduction of read- missions for neonatal jaundice. Osteopath Fam Physician,5:17-23.
Col, PV. Rama Mohan; Wg Cdr M Kumar; Maj R Pacharu,(2011). Mirizzi syndrome. MJAFI .67:280–281.
Dennery, PA.; Seidman, DS. and Stevenson, DK., (2001). Neonatal hyperbilirubinemia, N Engl J Med.,344:581–590.
Elizabete, P.; Maria, A M. and Fernando P. F., (2011). Systematic follow-up of hyperbilirubinemia in neonates with a gestational age of 35 to 37 weeks. J Pediatr.,87(4):301-306.
Gartner, L. M.; Herschel, M., (2001). Jaundice And Breastfeeding. Pediatric Clinics of North America, Vol.48(2): 389–400.
Huang, L. ; Bao, Y. ; Xu, Z. ; Lei, X. ; Chen, Y. ;Zhang, Y. ; Zhang, J. , (2013). Neonatal bilirubin levels and childhood asthma in the US Collaborative Perinatal Project, 1959–1965. Am J Epidemiol. 178(12):1691–1697.
Kaplan, M.; Hammerman C., (2002). Glucose-6- phosphate dehydrogenase deficiency: a potential source of severe neonatal hyperbilirubinaemia and kernicterus. Semin Neonatol.,7(2):121–128.
Kuzniewicz, M.W.; Escobar, G.J.; Wi, S.; Liljestrand, P.; McCulloch C. ; Newman, T.B. , (2008). Risk factors for severe hyper- bilirubinemia among infants with borderline bilirubin levels: a nested case-control study. J Pediatr. 153(2):234–240.
Logeshwaran, R.; Siva, K. P.; Kuldeep, S.; Pravin K. S., (2013). A Novel Design of Low-Cost LED Photo Therapy Equipment. Bachelor of Engineering, Associate Professor - Department of Biomedical Engineering, Sri Sivasubramaniya Nadar College of Engineering, Tamil Nadu, India Master of Science, Arizona State University, U.S.A. International Journal of Engineering & Technology Research, Vol (1), Issue 2: pp. 46-51.
Lynn, C.; Garfunkel, J.; Cynthia C.., (2002). Mosby's pediatric clinical advisor: instant diagnosis and treatment. Elsevier Health Sciences. pp. 200. ISBN 978-0-323-01049-8.
Maisels, MJ., (1999). Jaundice. In Neonatology, Pathophysiology & Management of the Newborn, eds. Avery GB, Fletcher MA, & MacDonald MG, pp. 765-820. Lippincott Williams & Wilkins, Philadelphia.
Maruo, Y.; Morioka, Y.; Fujito, H.; Nakahara, S.; Yanagi, T.; Matsui, K.; Mori, A.; Sato, H.; Tukey, R.H.; Takeuchi, Y., (2014). Bilirubin Uridine Diphosphate-Glucuronosyltransferase Variation Is a Genetic Basis of Breast Milk Jaundice..J Pediatr .165:36-41.
Mary Ann Liebert, (2010). ABM Clinical Protocol #22: Guidelines for Management of Jaundice in the Breastfeeding Infant Equal to or Greater Than 35 Weeks’ Gestation. The Academy of Breastfeeding Medicine Protocol Committee. Inc., vol.5(2).
Mehta, S.; Kumar, P.; Narang, A., (2005). A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia. J Pediatr .147:781-5.
National Blood Authority Australia (NBAA), (2012). Standing Council on Health. Criteria for the clinical use of intravenous immunoglobulin in Australia. Second edition.
National Institute for Health and Clinical Excellence (NIHCE), (2010). Neonatal jaundice. CG98. London: National Insititute for Health and Clinical Excellence.
Porter, ML. ; Dennis, BL.,(2002) . "Hyperbilirubinemia in the term new- born". Am Fam Physician, 65(4):599–606.
Practice parameter (PP), (1994). "management of hyperbilirubinemia in the healthy term newborn". Pediatrics .944 pt 1:558–62.
Rennie, J.; Burman-Roy, S. and Murphy, M.S., (2010). Neonatal jaundice: summary of NICE guidance. BMJ., 340:c2409.
Robert, M. ; Kliegman, Richard E. ;Behrman, Bal B. ;Jenson, S. Abramson, et al. ,(2011). "Neonatal Jaundice". Nelson text book of Pediatrics 19th Edition.Chapter96.3.page 603.
Watchko, J.F.; Maisels, MJ., (2003). Jaundice in low birthweight Infants: pathobiology and outcome. Arch Dis Child Fetal Neonatal Ed. 88: F455–F458.
Yang, W.C.; Zhao, L.L.; Li, Y.C.; Chen, C.H.; Chang, Y.J; Fu, Y.C.; Wu, H.P. et al. (2013). Bodyweight loss in predicting neonatal hyperbilirubinemia 72 hours after birth in term newborn infants. BMC Pediatrics, 13:154.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Sarah Ali Aljazaeri

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















